Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for transfusion-dependent beta-thalassemia
2018-001469-18Phase 2Completed
- Sponsor
- Dipartimento di Scienze della Vita e Biotecnologie dell'Università degli Studi di Ferrara
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in beta thalassemia, sponsored by Dipartimento di Scienze della Vita e Biotecnologie dell'Università degli Studi di Ferrara. Primary endpoint: Fetal hemoglobin level at day 360. Started May 2021; status: completed.
02
Drugs
sirolimus
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on 2018-001469-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001469-18.